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ABSTRACT 
Lung cancer is among the most common cancers with a high mortality rate worldwide. Despite 
the significant advances in diagnostic and therapeutic approaches, lung cancer prognoses and 
survival rates remain poor due to late diagnosis, drug resistance, and adverse effects. Therefore, 
new intervention therapies, such as the use of natural compounds with decreased toxicities, 
have been considered in lung cancer therapy. Curcumin, a natural occurring polyphenol derived 
from turmeric (Curcuma longa) has been studied extensively in recent years for its therapeutic 
effects. It has been shown that curcumin demonstrates anti-cancer effects in lung cancer 
through various mechanisms, including inhibition of cell proliferation, invasion, and 
metastasis, induction of apoptosis, epigenetic alterations, and regulation of microRNA 
expression. Several in vitro and in vivo studies have shown that these mechanisms are 
modulated by multiple molecular targets such as STAT3, EGFR, FOXO3a, TGF-β, eIF2α, 
COX-2, Bcl-2, PI3KAkt/mTOR, ROS, Fas/FasL, Cdc42, E-cadherin, MMPs, and adiponectin. 
In addition, limitations, strategies to overcome curcumin bioavailability, and potential side 
effects as well as clinical trials were also reviewed.  
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